In large breed dogs, dilated cardiomyopathy (DCM) is the main cause of congestive heart failure (CHF) and sudden cardiac death. The underlying etiology of DCM is usually not definitively identified; however, in predisposed breeds a hereditary etiology is often suspected. Other etiologies, such as toxins and infections, have also been documented or suspected to cause DCM in dogs.
View Article and Find Full Text PDFAntimoniate therapy, in association with allopurinol, is one of the first-line treatments of canine leishmaniasis (CanL). This study evaluates the potential adverse effects associated with aNm in the treatment of CanL through both a retrospective analysis and a long-term prospective study also aimed to investigate its efficacy. The retrospective study reviewed records of 87 dogs with CanL with at least one follow-up available during or at the end of therapy with aNm (Glucantime) at a dose of 50 mg/kg administered subcutaneously twice a day in association with allopurinol.
View Article and Find Full Text PDFTop Companion Anim Med
June 2024
Canine strongyloidosis by Strongyloides stercoralis is a parasitic disease emerging in Europe, which represents both a veterinary clinical issue and a public health challenge because of the zoonotic potential. The disease, not yet frequent in Europe, could induce severe clinical signs in dogs; thus, an early diagnosis and appropriate treatment are desirable. The aim of the present work is to retrospectively investigate the clinical and paraclinical findings in sick dogs naturally infected by S.
View Article and Find Full Text PDFParasitol Res
December 2023
Strongyloidiasis is a clinical issue both in humans and in dogs. Moreover, there are concerns about its zoonotic potential. We aimed to explore Strongyloides stercoralis epidemiology in Southern Italy in humans and dogs sharing the same environment in three different settings: (1) kennels (group K); (2) livestock farms (group L) and (3) agricultural farms (group A).
View Article and Find Full Text PDFBackground: Atrial fibrillation (AF) is the most common arrhythmia in dogs, most frequently diagnosed as chronic AF associated with a structural heart disease. The therapeutic strategy, in these cases, is based on the heart rate control and digoxin is one of the most used drugs.
Aim: The aim of this work was to study the serum digoxin concentration changes in dogs with AF under long-term treatment with digoxin.